Psychiatry Research: Neuroimaging
Volume 155, Issue 1 , Pages 67-73 , 15 May 2007

Relationship of brainstem raphe echogenicity and clinical findings in depressive states

  • Uwe Walter

      Affiliations

    • Department of Neurology, University of Rostock, Gehlsheimer Str. 20, D-18147 Rostock, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 381 494 9696; fax: +49 381 494 9632.
    • ,
  • Lara Prudente-Morrissey

      Affiliations

    • Department of Neurology, University of Rostock, Gehlsheimer Str. 20, D-18147 Rostock, Germany
    • ,
  • Sabine C. Herpertz

      Affiliations

    • Department of Psychiatry, University of Rostock, Rostock, Germany
    • ,
  • Reiner Benecke

      Affiliations

    • Department of Neurology, University of Rostock, Gehlsheimer Str. 20, D-18147 Rostock, Germany
    • ,
  • Jacqueline Hoeppner

      Affiliations

    • Department of Psychiatry, University of Rostock, Rostock, Germany

Received 18 October 2006 ,Accepted 6 December 2006.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  2. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001;25:892–903
  3. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience. 2002;114:807–815
  4. Bar KJ, Brehm S, Boettger MK, Wagner G, Boettger S, Sauer H. Decreased sensitivity to experimental pain in adjustment disorder. European Journal of Pain. 2005;10:467–471
  5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571
  6. Becker G, Struck M, Bogdahn U, Becker T. Echogenicity of the brainstem raphe in patients with major depression. Psychiatry Research. Neuroimaging. 1994;55:75–84
  7. Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, et al. Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biological Psychiatry. 1995;38:180–184
  8. Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. Journal of Neurology, Neurosurgery and Psychiatry. 1997;63:590–596
  9. Becker G, Berg D, Lesch KP, Becker T. Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. International Journal of Neuropsychopharmacology. 2001;4:21–31
  10. Berg D, Supprian T, Hofmann E, Zeiler B, Jager A, Lange KW, et al. Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. Journal of Neurology. 1999;246:1186–1193
  11. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. Journal of Neurology. 2001;248:684–689
  12. Fahn S, Elton RL Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In:  Fahn S,  Marsden CD,  Goldstein M,  Calne DB editor. Recent Developments in Parkinson's Disease II. 1st ed.. New York: Macmillan; 1987;p. 153–163
  13. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996;
  14. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189–198
  15. Frazer A. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. Journal of Clinical Psychiatry. 2001;62(Suppl. 12):16–23
  16. Geyer MA, Puerto A, Dawsey WJ, Knapp S, Bullard WP, Mandell AJ. Histologic and enzymatic studies of the mesolimbic and mesostriatal serotonergic pathways. Brain Research. 1976;106:241–256
  17. Hameed U, Schwartz TL, Malhotra K, West RL, Bertone F. Antidepressant treatment in the primary care office: outcomes for adjustment disorder versus major depression. Annals of Clinical Psychiatry. 2005;17:77–81
  18. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 1967;6:278–296
  19. Hirschfeld RM, Klerman GL, Andreasen NC, Clayton PJ, Keller MB. Situational major depressive disorder. Archives of General Psychiatry. 1987;42:1109–1114
  20. Jones R, Yates WR, Williams S, Zhou M, Hardman L. Outcome for adjustment disorder with depressed mood: comparison with other mood disorders. Journal of Affective Disorders. 1999;55:55–61
  21. Kessing LV. Diagnostic stability in depressive disorder as according to ICD-10 in clinical practice. Psychopathology. 2005;38:32–37
  22. Kugaya A, Sanacora G, Staley JK, Malison RT, Bozkurt A, Khan S, et al. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biological Psychiatry. 2004;56:497–502
  23. Meltzer CC, Price JC, Mathis CA, Butters MA, Ziolko SK, Moses-Kolko E, et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology. 2004;29:2258–2265
  24. Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry. 2004;61:1271–1279
  25. National Institute of Mental Health . CGI: Clinical Global Impressions. In:  Guy W editors. Early Clinical Drug Evaluation Unit (ECDEU) Assessment for Psychopharmacology, Rev. Ed. Rockville, MD: National Institute of Mental Health; 1976;p. 217–222
  26. Polyakova I, Knobler HY, Ambrumova A, Lerner V. Characteristics of suicidal attempts in major depression versus adjustment reactions. Journal of Affective Disorders. 1998;47:159–167
  27. Sobin C, Mayer L, Endicott J. The Motor Agitation and Retardation Scale: a scale for the assessment of motor abnormalities in depressed patients. Journal of Neuropsychiatry and Clinical Neurosciences. 1998;10:85–92
  28. Spalletta G, Troisi A, Saracco M, Ciani N, Pasini A. Symptom profile, Axis II comorbidity and suicidal behaviour in young males with DSM-III-R depressive illnesses. Journal of Affective Disorders. 1996;39:141–148
  29. Stahl SM, Grady MM, Moret C, Briley M. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectrums. 2005;10:732–747
  30. Supprian T, Reiche W, Schmitz B, Grunwald I, Backens M, Hofmann E, et al. MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls. Psychiatry Research. Neuroimaging. 2004;131:269–276
  31. Walter U, Krolikowski K, Tarnacka B, Benecke R, Czlonkowska A, Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology. 2005;64:1726–1732
  32. Walter U, Dressler D, Wolters A, Wittstock M, Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Movement Disorders. 2007;22:48–54

PII: S0925-4927(06)00225-3

doi: 10.1016/j.pscychresns.2006.12.001

Psychiatry Research: Neuroimaging
Volume 155, Issue 1 , Pages 67-73 , 15 May 2007

Article Tools

* Image Usage & Resolution